As we start the New Year, it is worth noting that this also marks the 4th and last issue of Volume III of IMMpress Magazine, a remarkable graduate-student led initiative from the Department of Immunology. Indeed, for the last three years, IMMpress has been having a major impact, by addressing important topics in our field, delving into pertinent aspects of graduate life and providing updates from our alumni. We all eagerly look forward to every issue of IMMpress Magazine, which Cat and Kieran, as co-editors-in-chief, brilliantly deliver again.
For this issue, the exceptional IMMpress team brings us a thoughtful set of articles on the topic of Clinical Immunology, with features on the evolving landscape of flow cytometry-based diagnostics for clinical research, the vexing placebo effect, and changes to MD/PhD funding within CIHR. There is also an excellent interview about Open Source Drug design, perhaps the way of the future to reduce drug costs and other pitfalls of “Big Pharma”. On that note, IMMpress also addresses recent uproars on price gauging for life-saving drugs, and the role, if any, of the government to regulate such issues. There is also a wonderful alumni interview with Gloria Lin that brings to light many of the challenges faced by our recent graduates. Finally, IMMpress pays tribute to our recently lost colleague, Rick Miller, who was the inaugural chair of the Department of Immunology.
Together with the usual high level of design sophistication, insightful editorials and perspectives, our Immunology graduate students continue to make IMMpress a must read for all of us. I am again very thankful to the editorial team for their terrific efforts.
As per usual, I hope you will enjoy this issue of IMMpress Magazine, and importantly whether you are an alumnus of the department or a prospective student, I really look forward to hearing from you.